News Scope Fluidics S.A.

Stocks

SCP

PLSCPFL00018

Biotechnology & Medical Research

Delayed Warsaw S.E. 06:35:16 2026-10-20 am EDT			5-day change	1st Jan Change
129.00 ^PLN	-1.23%		-2.42%	-5.29%

Sep. 30	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE

All News

Mentions Relevance

Sep. 30	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
May. 15	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE
May. 15	Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 21	Scope Fluidics unit Bacteromic starts collaboration with US research center for FDA registration trials	RE
Mar. 25	Scope Fluidics FY net loss at 46.4 million zlotys	RE
Mar. 25	Scope Fluidics S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 09	Scope Fluidics updates objectives for Bacteromic project for 2026-2027	RE
Feb. 20	Scope Fluidics obtains CE-IVDR certification for Bacteromic System	RE
Feb. 11	Scope Fluidics unit adopts plan for production readiness for Bacteromic system panels	RE
Jan. 21	Scope Fluidics unit signs framework distribution deal with SC Elta 90 Medical Research	RE
Jan. 08	Scope Fluidics signs distribution deal for Bacteromic system in Turkey	RE
Dec. 23	Scope Fluidics says unit Bacteromic ends cooperation with MicroLiquid	RE
Dec. 12	Scope Fluidics says unit receives conditional grant approval for Hybolic project	RE
Dec. 01	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Dec. 01	Scope Fluidics Q3 net loss at 11.4 million zlotys	RE
Nov. 03	Scope Fluidics says shareholder sells stake in company	RE
25-10-29	Scope Fluidics says shareholders complete ABB process for 16% of stake	RE
25-10-27	Scope Fluidics starts ABB process	RE
25-10-27	Scope Fluidics to raise share capital via issue of up to 0.4 million new shares	RE
25-09-26	Scope Fluidics extends collaboration for FDA certification	RE
25-09-19	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-09-19	Scope Fluidics Q2 net loss at 8.6 mln zlotys	RE
25-09-16	Scope Fluidics approves timeline change for Hybolic project goal	RE
25-09-15	Scope Fluidics board okays EIB financing pursuit for Bacteromic	RE